This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Craig Antonyjoseph Laferriere: Innovator in Vaccine Development
Introduction
Craig Antonyjoseph Laferriere is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of vaccine development, particularly in the area of bacterial polysaccharide antigen vaccines. His work is crucial in advancing medical science and improving public health.
Latest Patents
Laferriere holds a patent related to a vaccine that focuses on bacterial polysaccharides conjugated to protein D. This invention is aimed at enhancing the efficacy of vaccines against bacterial infections. His innovative approach is expected to have a positive impact on vaccine technology.
Career Highlights
Laferriere is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. His role in the company has allowed him to work on groundbreaking research and development projects that contribute to global health solutions.
Collaborations
He has collaborated with esteemed colleagues such as Carine Capiau and Marguerite Deschamps. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Craig Antonyjoseph Laferriere is a prominent figure in the field of vaccine research, with a focus on bacterial polysaccharide antigen vaccines. His contributions and collaborations continue to shape the future of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile